GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Yizhong Pharmaceutical Co Ltd (SHSE:688091) » Definitions » PE Ratio

Shanghai Yizhong Pharmaceutical Co (SHSE:688091) PE Ratio : 123.75 (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Yizhong Pharmaceutical Co PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-15), Shanghai Yizhong Pharmaceutical Co's share price is ¥39.60. Shanghai Yizhong Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.32. Therefore, Shanghai Yizhong Pharmaceutical Co's PE Ratio for today is 123.75.

Warning Sign:

Shanghai Yizhong Pharmaceutical Co Ltd stock PE Ratio (=128.59) is close to 2-year high of 135.56

During the past 7 years, Shanghai Yizhong Pharmaceutical Co's highest PE Ratio was 500.41. The lowest was 27.35. And the median was 56.85.

Shanghai Yizhong Pharmaceutical Co's EPS (Diluted) for the three months ended in Sep. 2024 was ¥0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.32.

As of today (2024-12-15), Shanghai Yizhong Pharmaceutical Co's share price is ¥39.60. Shanghai Yizhong Pharmaceutical Co's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.32. Therefore, Shanghai Yizhong Pharmaceutical Co's PE Ratio without NRI ratio for today is 125.32.

During the past 7 years, Shanghai Yizhong Pharmaceutical Co's highest PE Ratio without NRI was 495.30. The lowest was 26.80. And the median was 56.69.

Shanghai Yizhong Pharmaceutical Co's EPS without NRI for the three months ended in Sep. 2024 was ¥0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.32.

During the past 12 months, Shanghai Yizhong Pharmaceutical Co's average EPS without NRI Growth Rate was -69.70% per year.

During the past 7 years, Shanghai Yizhong Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was -8.70% per year. The lowest was -14.70% per year. And the median was -11.70% per year.

Shanghai Yizhong Pharmaceutical Co's EPS (Basic) for the three months ended in Sep. 2024 was ¥0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.32.

Back to Basics: PE Ratio


Shanghai Yizhong Pharmaceutical Co PE Ratio Historical Data

The historical data trend for Shanghai Yizhong Pharmaceutical Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Yizhong Pharmaceutical Co PE Ratio Chart

Shanghai Yizhong Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio
Get a 7-Day Free Trial N/A N/A At Loss 64.06 62.71

Shanghai Yizhong Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.51 62.71 39.91 46.10 110.69

Competitive Comparison of Shanghai Yizhong Pharmaceutical Co's PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Yizhong Pharmaceutical Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Yizhong Pharmaceutical Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Yizhong Pharmaceutical Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Yizhong Pharmaceutical Co's PE Ratio falls into.



Shanghai Yizhong Pharmaceutical Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Shanghai Yizhong Pharmaceutical Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=39.60/0.320
=123.75

Shanghai Yizhong Pharmaceutical Co's Share Price of today is ¥39.60.
Shanghai Yizhong Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.32.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Shanghai Yizhong Pharmaceutical Co  (SHSE:688091) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Shanghai Yizhong Pharmaceutical Co PE Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Yizhong Pharmaceutical Co's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Yizhong Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
79 Renqi Road, Fengxian District, Shanghai, CHN, 201403
Shanghai Yizhong Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating research and development, production and sales. It is committed towards the development of new dosage forms of anti-tumor drugs and related products.
Executives
Du Xue Hang Director
Sun Jing Directors, senior managers, core technical personn
Zhou Jin Song Directors, senior managers, core technical personn
Li Duan Directors, senior managers, core technical personn

Shanghai Yizhong Pharmaceutical Co Headlines

No Headlines